Report Detail
Global Multi Cancer Screening Market 2023 by Company, Regions, Type and Application, Forecast to 2029
- RnM4535350 |
- 09 June, 2023 |
- Global |
- 100 Pages |
- GIR (Global Info Research) |
- Medical Devices & Consumables
According to our (Global Info Research) latest study, the global Multi Cancer Screening market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Multi Cancer Screening market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Multi Cancer Screening market size and forecasts, in consumption value ($ Million), 2018-2029
Global Multi Cancer Screening market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Multi Cancer Screening market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Multi Cancer Screening market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Multi Cancer Screening
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Multi Cancer Screening market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Guardant Health, GRAIL, Burning Rock, Thermo Fisher Scientific and Exact Sciences Corporation, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Multi Cancer Screening market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Laboratory Developed Tests (LDTs)
In-Vitro Diagnostics (IVDs)
Market segment by Application
Hospitals
Clinic
Market segment by players, this report covers
Guardant Health
GRAIL
Burning Rock
Thermo Fisher Scientific
Exact Sciences Corporation
Fulgent Genetics
Genecast Biotechnology
Agilent Technologies
Atara Biotherapeutics
Konica Minolta
Tempus
Myriad Genetics
Laboratory Corporation
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Multi Cancer Screening product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Multi Cancer Screening, with revenue, gross margin and global market share of Multi Cancer Screening from 2018 to 2023.
Chapter 3, the Multi Cancer Screening competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Multi Cancer Screening market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Multi Cancer Screening.
Chapter 13, to describe Multi Cancer Screening research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope of Multi Cancer Screening
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Multi Cancer Screening by Type
- 1.3.1 Overview: Global Multi Cancer Screening Market Size by Type: 2018 Versus 2022 Versus 2029
- 1.3.2 Global Multi Cancer Screening Consumption Value Market Share by Type in 2022
- 1.3.3 Laboratory Developed Tests (LDTs)
- 1.3.4 In-Vitro Diagnostics (IVDs)
- 1.4 Global Multi Cancer Screening Market by Application
- 1.4.1 Overview: Global Multi Cancer Screening Market Size by Application: 2018 Versus 2022 Versus 2029
- 1.4.2 Hospitals
- 1.4.3 Clinic
- 1.5 Global Multi Cancer Screening Market Size & Forecast
- 1.6 Global Multi Cancer Screening Market Size and Forecast by Region
- 1.6.1 Global Multi Cancer Screening Market Size by Region: 2018 VS 2022 VS 2029
- 1.6.2 Global Multi Cancer Screening Market Size by Region, (2018-2029)
- 1.6.3 North America Multi Cancer Screening Market Size and Prospect (2018-2029)
- 1.6.4 Europe Multi Cancer Screening Market Size and Prospect (2018-2029)
- 1.6.5 Asia-Pacific Multi Cancer Screening Market Size and Prospect (2018-2029)
- 1.6.6 South America Multi Cancer Screening Market Size and Prospect (2018-2029)
- 1.6.7 Middle East and Africa Multi Cancer Screening Market Size and Prospect (2018-2029)
2 Company Profiles
- 2.1 Guardant Health
- 2.1.1 Guardant Health Details
- 2.1.2 Guardant Health Major Business
- 2.1.3 Guardant Health Multi Cancer Screening Product and Solutions
- 2.1.4 Guardant Health Multi Cancer Screening Revenue, Gross Margin and Market Share (2018-2023)
- 2.1.5 Guardant Health Recent Developments and Future Plans
- 2.2 GRAIL
- 2.2.1 GRAIL Details
- 2.2.2 GRAIL Major Business
- 2.2.3 GRAIL Multi Cancer Screening Product and Solutions
- 2.2.4 GRAIL Multi Cancer Screening Revenue, Gross Margin and Market Share (2018-2023)
- 2.2.5 GRAIL Recent Developments and Future Plans
- 2.3 Burning Rock
- 2.3.1 Burning Rock Details
- 2.3.2 Burning Rock Major Business
- 2.3.3 Burning Rock Multi Cancer Screening Product and Solutions
- 2.3.4 Burning Rock Multi Cancer Screening Revenue, Gross Margin and Market Share (2018-2023)
- 2.3.5 Burning Rock Recent Developments and Future Plans
- 2.4 Thermo Fisher Scientific
- 2.4.1 Thermo Fisher Scientific Details
- 2.4.2 Thermo Fisher Scientific Major Business
- 2.4.3 Thermo Fisher Scientific Multi Cancer Screening Product and Solutions
- 2.4.4 Thermo Fisher Scientific Multi Cancer Screening Revenue, Gross Margin and Market Share (2018-2023)
- 2.4.5 Thermo Fisher Scientific Recent Developments and Future Plans
- 2.5 Exact Sciences Corporation
- 2.5.1 Exact Sciences Corporation Details
- 2.5.2 Exact Sciences Corporation Major Business
- 2.5.3 Exact Sciences Corporation Multi Cancer Screening Product and Solutions
- 2.5.4 Exact Sciences Corporation Multi Cancer Screening Revenue, Gross Margin and Market Share (2018-2023)
- 2.5.5 Exact Sciences Corporation Recent Developments and Future Plans
- 2.6 Fulgent Genetics
- 2.6.1 Fulgent Genetics Details
- 2.6.2 Fulgent Genetics Major Business
- 2.6.3 Fulgent Genetics Multi Cancer Screening Product and Solutions
- 2.6.4 Fulgent Genetics Multi Cancer Screening Revenue, Gross Margin and Market Share (2018-2023)
- 2.6.5 Fulgent Genetics Recent Developments and Future Plans
- 2.7 Genecast Biotechnology
- 2.7.1 Genecast Biotechnology Details
- 2.7.2 Genecast Biotechnology Major Business
- 2.7.3 Genecast Biotechnology Multi Cancer Screening Product and Solutions
- 2.7.4 Genecast Biotechnology Multi Cancer Screening Revenue, Gross Margin and Market Share (2018-2023)
- 2.7.5 Genecast Biotechnology Recent Developments and Future Plans
- 2.8 Agilent Technologies
- 2.8.1 Agilent Technologies Details
- 2.8.2 Agilent Technologies Major Business
- 2.8.3 Agilent Technologies Multi Cancer Screening Product and Solutions
- 2.8.4 Agilent Technologies Multi Cancer Screening Revenue, Gross Margin and Market Share (2018-2023)
- 2.8.5 Agilent Technologies Recent Developments and Future Plans
- 2.9 Atara Biotherapeutics
- 2.9.1 Atara Biotherapeutics Details
- 2.9.2 Atara Biotherapeutics Major Business
- 2.9.3 Atara Biotherapeutics Multi Cancer Screening Product and Solutions
- 2.9.4 Atara Biotherapeutics Multi Cancer Screening Revenue, Gross Margin and Market Share (2018-2023)
- 2.9.5 Atara Biotherapeutics Recent Developments and Future Plans
- 2.10 Konica Minolta
- 2.10.1 Konica Minolta Details
- 2.10.2 Konica Minolta Major Business
- 2.10.3 Konica Minolta Multi Cancer Screening Product and Solutions
- 2.10.4 Konica Minolta Multi Cancer Screening Revenue, Gross Margin and Market Share (2018-2023)
- 2.10.5 Konica Minolta Recent Developments and Future Plans
- 2.11 Tempus
- 2.11.1 Tempus Details
- 2.11.2 Tempus Major Business
- 2.11.3 Tempus Multi Cancer Screening Product and Solutions
- 2.11.4 Tempus Multi Cancer Screening Revenue, Gross Margin and Market Share (2018-2023)
- 2.11.5 Tempus Recent Developments and Future Plans
- 2.12 Myriad Genetics
- 2.12.1 Myriad Genetics Details
- 2.12.2 Myriad Genetics Major Business
- 2.12.3 Myriad Genetics Multi Cancer Screening Product and Solutions
- 2.12.4 Myriad Genetics Multi Cancer Screening Revenue, Gross Margin and Market Share (2018-2023)
- 2.12.5 Myriad Genetics Recent Developments and Future Plans
- 2.13 Laboratory Corporation
- 2.13.1 Laboratory Corporation Details
- 2.13.2 Laboratory Corporation Major Business
- 2.13.3 Laboratory Corporation Multi Cancer Screening Product and Solutions
- 2.13.4 Laboratory Corporation Multi Cancer Screening Revenue, Gross Margin and Market Share (2018-2023)
- 2.13.5 Laboratory Corporation Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Multi Cancer Screening Revenue and Share by Players (2018-2023)
- 3.2 Market Share Analysis (2022)
- 3.2.1 Market Share of Multi Cancer Screening by Company Revenue
- 3.2.2 Top 3 Multi Cancer Screening Players Market Share in 2022
- 3.2.3 Top 6 Multi Cancer Screening Players Market Share in 2022
- 3.3 Multi Cancer Screening Market: Overall Company Footprint Analysis
- 3.3.1 Multi Cancer Screening Market: Region Footprint
- 3.3.2 Multi Cancer Screening Market: Company Product Type Footprint
- 3.3.3 Multi Cancer Screening Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Multi Cancer Screening Consumption Value and Market Share by Type (2018-2023)
- 4.2 Global Multi Cancer Screening Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
- 5.1 Global Multi Cancer Screening Consumption Value Market Share by Application (2018-2023)
- 5.2 Global Multi Cancer Screening Market Forecast by Application (2024-2029)
6 North America
- 6.1 North America Multi Cancer Screening Consumption Value by Type (2018-2029)
- 6.2 North America Multi Cancer Screening Consumption Value by Application (2018-2029)
- 6.3 North America Multi Cancer Screening Market Size by Country
- 6.3.1 North America Multi Cancer Screening Consumption Value by Country (2018-2029)
- 6.3.2 United States Multi Cancer Screening Market Size and Forecast (2018-2029)
- 6.3.3 Canada Multi Cancer Screening Market Size and Forecast (2018-2029)
- 6.3.4 Mexico Multi Cancer Screening Market Size and Forecast (2018-2029)
7 Europe
- 7.1 Europe Multi Cancer Screening Consumption Value by Type (2018-2029)
- 7.2 Europe Multi Cancer Screening Consumption Value by Application (2018-2029)
- 7.3 Europe Multi Cancer Screening Market Size by Country
- 7.3.1 Europe Multi Cancer Screening Consumption Value by Country (2018-2029)
- 7.3.2 Germany Multi Cancer Screening Market Size and Forecast (2018-2029)
- 7.3.3 France Multi Cancer Screening Market Size and Forecast (2018-2029)
- 7.3.4 United Kingdom Multi Cancer Screening Market Size and Forecast (2018-2029)
- 7.3.5 Russia Multi Cancer Screening Market Size and Forecast (2018-2029)
- 7.3.6 Italy Multi Cancer Screening Market Size and Forecast (2018-2029)
8 Asia-Pacific
- 8.1 Asia-Pacific Multi Cancer Screening Consumption Value by Type (2018-2029)
- 8.2 Asia-Pacific Multi Cancer Screening Consumption Value by Application (2018-2029)
- 8.3 Asia-Pacific Multi Cancer Screening Market Size by Region
- 8.3.1 Asia-Pacific Multi Cancer Screening Consumption Value by Region (2018-2029)
- 8.3.2 China Multi Cancer Screening Market Size and Forecast (2018-2029)
- 8.3.3 Japan Multi Cancer Screening Market Size and Forecast (2018-2029)
- 8.3.4 South Korea Multi Cancer Screening Market Size and Forecast (2018-2029)
- 8.3.5 India Multi Cancer Screening Market Size and Forecast (2018-2029)
- 8.3.6 Southeast Asia Multi Cancer Screening Market Size and Forecast (2018-2029)
- 8.3.7 Australia Multi Cancer Screening Market Size and Forecast (2018-2029)
9 South America
- 9.1 South America Multi Cancer Screening Consumption Value by Type (2018-2029)
- 9.2 South America Multi Cancer Screening Consumption Value by Application (2018-2029)
- 9.3 South America Multi Cancer Screening Market Size by Country
- 9.3.1 South America Multi Cancer Screening Consumption Value by Country (2018-2029)
- 9.3.2 Brazil Multi Cancer Screening Market Size and Forecast (2018-2029)
- 9.3.3 Argentina Multi Cancer Screening Market Size and Forecast (2018-2029)
10 Middle East & Africa
- 10.1 Middle East & Africa Multi Cancer Screening Consumption Value by Type (2018-2029)
- 10.2 Middle East & Africa Multi Cancer Screening Consumption Value by Application (2018-2029)
- 10.3 Middle East & Africa Multi Cancer Screening Market Size by Country
- 10.3.1 Middle East & Africa Multi Cancer Screening Consumption Value by Country (2018-2029)
- 10.3.2 Turkey Multi Cancer Screening Market Size and Forecast (2018-2029)
- 10.3.3 Saudi Arabia Multi Cancer Screening Market Size and Forecast (2018-2029)
- 10.3.4 UAE Multi Cancer Screening Market Size and Forecast (2018-2029)
11 Market Dynamics
- 11.1 Multi Cancer Screening Market Drivers
- 11.2 Multi Cancer Screening Market Restraints
- 11.3 Multi Cancer Screening Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
- 11.5 Influence of COVID-19 and Russia-Ukraine War
- 11.5.1 Influence of COVID-19
- 11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
- 12.1 Multi Cancer Screening Industry Chain
- 12.2 Multi Cancer Screening Upstream Analysis
- 12.3 Multi Cancer Screening Midstream Analysis
- 12.4 Multi Cancer Screening Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Multi Cancer Screening. Industry analysis & Market Report on Multi Cancer Screening is a syndicated market report, published as Global Multi Cancer Screening Market 2023 by Company, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Multi Cancer Screening market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
